| John P Joyce, MD | |
|
1000 Highway 12, Hettinger, ND 58639 | |
| (701) 567-4561 | |
| Not Available |
| Full Name | John P Joyce |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1000 Highway 12, Hettinger, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144315441 | NPI | - | NPPES |
| 10776 | Other | ND BC/BS | |
| 13691 | Medicaid | ND | |
| 27276 | Other | SIOUX VALLEY | |
| 45034068812 | Medicaid | NE | |
| 4999832 | Other | WELMARCK | |
| 3018140 | Medicaid | WA | |
| 123993 | Other | WORKER'S COMP | |
| 7776100 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4267 (North Dakota) | Primary |
| Entity Name | West River Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174606271 PECOS PAC ID: 0042127045 Enrollment ID: O20040128001023 |
News Archive
Breathing xenon gas can help protect the infant brain from damage caused by oxygen deprivation, but the xenon's high cost and scarcity has precluded its widespread use.
The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.
AcelRx Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
The latest issue of the journal Cell carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. In a study that challenges currently held views, researchers at the Instituto Gulbenkian de Ci-ncia, in Portugal, unravel the molecular mechanism whereby sickle cell hemoglobin confers a survival advantage against malaria, the disease caused by Plasmodium infection.
An innovative collaboration among scientists at Los Alamos National Laboratory, Fox Chase Cancer Center and the University of Tennessee has successfully applied neutron diffraction to create a three-dimensional map of the structure of the enzyme D-xylose isomerase.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John P Joyce, MD 1100 Highway 12, Hettinger, ND 58639-7533 Ph: (701) 567-6130 | John P Joyce, MD 1000 Highway 12, Hettinger, ND 58639 Ph: (701) 567-4561 |
News Archive
Breathing xenon gas can help protect the infant brain from damage caused by oxygen deprivation, but the xenon's high cost and scarcity has precluded its widespread use.
The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.
AcelRx Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
The latest issue of the journal Cell carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. In a study that challenges currently held views, researchers at the Instituto Gulbenkian de Ci-ncia, in Portugal, unravel the molecular mechanism whereby sickle cell hemoglobin confers a survival advantage against malaria, the disease caused by Plasmodium infection.
An innovative collaboration among scientists at Los Alamos National Laboratory, Fox Chase Cancer Center and the University of Tennessee has successfully applied neutron diffraction to create a three-dimensional map of the structure of the enzyme D-xylose isomerase.
› Verified 2 days ago
Catherine E Shirek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Highway 12, Hettinger, ND 58639 Phone: 701-567-4561 | |
Thomas E Jacobsen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1000 Highway 12, Hettinger, ND 58639 Phone: 701-567-4561 | |
Robert E Grossman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Highway 12, Hettinger, ND 58639 Phone: 701-567-4561 | |
Frank A Thorngren, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Highway 12, Hettinger, ND 58639 Phone: 701-567-4561 | |
Joseph M Mattson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Highway 12, Hettinger, ND 58639 Phone: 701-567-4561 | |
Terrance R Mack, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Highway 12, Hettinger, ND 58639 Phone: 701-567-4561 |